What You Should Know:

– Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity.

– To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and people with diabetes as a public service until the greatest threat of the pandemic has subsided.

Glooko, a leading diabetes software company that enables people with diabetes and clinicians to manage care in real-time, today announced they are providing a no-charge remote care solution that provides live patient-to-clinician connectivity to serve the diabetic community during the COVID-19 pandemic. This public service is being made available to medical clinics and people with diabetes across 25 countries and 15 languages where Glooko technology is already provided.

Leveraging Remote Care Models to Limit Exposure to COVID-19

As many efforts undertaken in our communities are aimed at reducing the chances of being exposed to and spreading COVID-19, individuals who have chronic conditions like diabetes and contract the virus appear to be at a higher risk for developing complications; as such limiting exposure is critical. For certain appointments, healthcare professionals may determine that the patient and their care team would be best served by a remote review of the patient’s personal diabetes data and a corresponding telehealth consult, reserving in-office visits only for those appointments where a patient’s medical status truly requires in-person treatment.

The Glooko product suite contains the Glooko and diasend® by Glooko diabetes management solutions, which integrate with many of the leading EHR systems used today. Both systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.